GE Healthcare announces the first global installation in France of the
Discovery IGS 730 system for hybrid Operating Rooms and imaging
departments. It will allow performing complex minimally-invasive
endovascular and percutaneous procedures on inoperable patients
suffering from cardiovascular pathologies such as ruptured aorta
aneurysms, fainting spells or cerebrovascular accidents. "The Discovery
IGS 730 is a true innovation allowing us to conduct complex minimally
invasive hybrid procedures in a secure setting. With this technology we
are treating "high risk” patients unfit for open surgery. In a year,
this technology will allow us to perform 500 complex aortic repairs in
such patients. The majority of patients will have a reduced hospital
stay and a quick return to normal activity. In addition, in terms of
mobility/patient access and the ergonomics of the operating room, this
is a huge step forward”, said Prof. Haulon, Head of Vascular Surgery
Department, University Hospital of Lille, France.
World's first installation and clinical use of GE Healthcare’s Discovery IGS 730 at the Lille University Hospital in France.
A major innovation developed and produced in France: Discovery IGS 730
The hybrid operating room allows both open surgery and catheter-based
imaging therapies to take place in the same operating room. The hybrid
OR enables multiple physicians (surgeons, Interventionalist, nurses,
anaesthesiologists, and technicians) to perform a new spectrum of
minimally invasive therapies with the goal of ultimately enabling better
patient care. These complex minimally-invasive endovascular and
percutaneous procedures will allow discharging patients much faster (5
days in comparison to an average of 10 days) and reduce patient
rehabilitation.
"In designing the Discovery IGS 730, it was always our goal to provide
the latest in interventional efficiency – with high precision imaging
capability and exceptional in-room mobility. This solution aims to
accommodate a wide range of minimally invasive and surgical procedures.
Due to the technological innovation and the advanced application
portfolio available, we hope it will allow our customers to explore and
discover new ways within both the Interventional and the Operating
Room.” says Chantal Le Chat, General Manager, Premium Angiography, GE
Healthcare, Detection & Guidance Solutions.
The Discovery IGS 730 is a laser-guided, mobile gantry, a first-of-its
kind in interventional imaging. The system is neither floor nor ceiling
mounted and enables full patient access, creating an interventional
environment without boundaries. It has the mobility of a C-arm with the
power and image quality of a fixed system, allowing multiple parking
possibilities, while helping maintain sterility for a flexible and
secure OR environment. It is intended for oncology (hepatic and bone
tumors), neurology (aneurysms and brain tumors) as well as
cardiovascular patients (stent appositions). Discovery IGS 730 is the
only x-ray angiographic medical imaging system with such mobility in the
world.
Discovery IGS 730, the outcome of a 32 million Euros investment in
France
In total, 12 international patents have been registered for this
ground-breaking technological innovation. Discovery IGS 730 has been
developed within the IRIMI project, a public-private partnership that
involved several French laboratories and partially funded by the French
government (IRIMI project).
"With the installation of the Discovery IGS 730 in France, our R&D
factory of Buc (Parisian Region) has become the birthplace of a
ground-breaking innovation in worldwide surgery. With this, our 420
France-based researchers have proven to be able to find technological
innovations that allow new treatments, reduce risks for the patients and
provide solutions for health professionals” declared Robert Sigal, CEO,
GE Healthcare France.
About GE Healthcare
GE Healthcare provides transformational medical technologies and
services that are shaping a new age of patient care. Our broad expertise
in medical imaging and information technologies, medical diagnostics,
patient monitoring systems, drug discovery, biopharmaceutical
manufacturing technologies, performance improvement and performance
solutions services help our customers to deliver better care to more
people around the world at a lower cost. In addition, we partner with
healthcare leaders, striving to leverage the global policy change
necessary to implement a successful shift to sustainable healthcare
systems. Our "healthymagination” vision for the future invites the world
to join us on our journey as we continuously develop innovations focused
on increasing access and improving quality and affordability around the
world. Headquartered in the United Kingdom, GE Healthcare is a unit of
General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees
are committed to serving healthcare professionals and their patients in
more than 100 countries. For more information about GE Healthcare, visit
our website at www.gehealthcare.com.
For our latest news, please visit http://newsroom.gehealthcare.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121211006256/en/
